May 20, 2018 2:21 PM ET


Company Overview of Avion Pharmaceuticals, LLC

Company Overview

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, develops and markets a portfolio of pharmaceutical and dietary supplement products in the women’s heath and dermatology therapeutic areas. It offers Prenate, which improves the nutritional status of women throughout pregnancy and in the postnatal period for lactating and non-lactating mothers; Nicomide, which contains niacin, zinc, and folic acid, and addresses the inflammatory response before acne lesions; and PRENATE MINI, a blended vitamin incorporating QUATREFOLIC, DHA, 13 vitamins and minerals, and 25mg of blueberry extract. The company also provides PRENATE DHA, a blended vitamin incorporating QUATREFOLIC, DHA, and 8 vitam...

8505 Dunwoody Place

Atlanta, GA 30350

United States

Founded in 2010





Key Executives for Avion Pharmaceuticals, LLC

Chief Executive Officer and Chief Operation Officer
Compensation as of Fiscal Year 2017.

Avion Pharmaceuticals, LLC Key Developments

Avion Pharmaceuticals, LLC Announces Approval of First NDA in the Oral Contraceptive Category

Avion Pharmaceuticals, LLC received approval of its new drug application (NDA) for the oral contraceptive Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), the company's first internally developed NDA. Avion expects to commercially launch this new oral contraceptive to the prescribing community in Spring 2018. The approval of Balcoltra, the only branded oral contraceptive combining 0.1 mg levonorgestrel, 20 mcg ethinyl estradiol tablets and ferrous bisglycinate tablets 36.5 mg, marks a milestone for Avion Pharmaceuticals and a win for the women's health category by allowing women to have access to a clinically effective form of oral contraception for pregnancy prevention.

Avion Pharmaceuticals, LLC Renews Ongoing Partnership with Gnosis, S.P.A., to License Quatrefolic, Body-Ready Folate, through Patent Life of 2028

Avion Pharmaceuticals, LLC recently announced it has solidified its continuing partnership with Gnosis S.P.A. to provide Quatrefolic®, the fourth-generation folate, as part of the Prenate® prescription prenatal vitamin portfolio. As a result of the recent agreement, Avion will provide Quatrefolic® through the duration of its patent life, which runs through 2028. Quatrefolic® ((6S)-5 methyltetrahydrofolate glucosamine salt) is a patented and unique body-ready form of folate that is an important component of prenatal nutritional support for both expecting mothers or women trying to conceive. Folic acid helps prevent neural tube defects (NTD) such as spina bifida. Up to 50% of American women have MTHFR polymorphism, which does not allow the body to metabolize folic acid that is available through diet or nutritional supplements. 1,2 Quatrefolic® folate, available in all Prenate® prescription prenatals, is delivered in the form that is already in the biologically active form for the body to use and overcomes the MTHFR polymorphism common in women allowing all women, regardless of their genetic predisposition, to absorb folate and enjoy the protective benefits as they prepare for motherhood.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Avion Pharmaceuticals, LLC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at